fenofibrate has been researched along with Graves Ophthalmopathy in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
Graves Ophthalmopathy: An autoimmune disorder of the EYE, occurring in patients with Graves disease. Subtypes include congestive (inflammation of the orbital connective tissue), myopathic (swelling and dysfunction of the extraocular muscles), and mixed congestive-myopathic ophthalmopathy.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Antonelli, A | 2 |
Ferrari, SM | 2 |
Frascerra, S | 2 |
Ruffilli, I | 2 |
Gelmini, S | 2 |
Minuto, M | 1 |
Pupilli, C | 2 |
Miccoli, P | 1 |
Sellari-Franceschini, S | 2 |
Ferrannini, E | 2 |
Fallahi, P | 2 |
Bernini, G | 1 |
2 other studies available for fenofibrate and Graves Ophthalmopathy
Article | Year |
---|---|
Peroxisome proliferator-activated receptor-α agonists modulate CXCL9 and CXCL11 chemokines in Graves' ophthalmopathy fibroblasts and preadipocytes.
Topics: Adipocytes; Chemokine CXCL11; Chemokine CXCL9; Enzyme-Linked Immunosorbent Assay; Eye; Fenofibrate; | 2012 |
β (CCL2) and α (CXCL10) chemokine modulations by cytokines and peroxisome proliferator-activated receptor-α agonists in Graves' ophthalmopathy.
Topics: Cells, Cultured; Chemokine CCL2; Chemokine CXCL10; Fenofibrate; Fibroblasts; Graves Ophthalmopathy; | 2012 |